###begin article-title 0
The TCL1A Oncoprotein Interacts Directly with the NF-kappaB Inhibitor IkappaB
###end article-title 0
###begin p 1
Conceived and designed the experiments: MHS CR STA. Performed the experiments: VR GD MHS SB. Analyzed the data: VR GD MHS CR STA. Contributed reagents/materials/analysis tools: GD MHS SB. Wrote the paper: STA.
###end p 1
###begin p 2
Current address: Universite de Franche-Comte, IFR 133, UFR-ST, Equipe E3922, Besancon, France
###end p 2
###begin p 3
###xml 228 231 228 231 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">via</italic>
###xml 847 855 835 843 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 748 753 <span type="species:ncbi:4932">yeast</span>
The T cell leukaemia/lymphoma 1A (TCL1A) oncoprotein plays key roles in several B and T cell malignancies. Lacking enzymatic activity, TCL1A's transforming action was linked to its capacity to co-activate the protein kinase AKT via binding to its pleckstrin homology (PH) domain. However, perturbation of AKT signalling alone was recently shown insufficient to explain TCL1A oncogenesis, suggesting that TCL1A has additional cellular partners. Searching for such additional targets, we found that TCL1A binds specifically and directly to the ankyrin domain of IkappaB, the inhibitor of the NF-kappaB transcription factors. Through binding assays and a structural analysis by small angle X-ray scattering, we show that TCL1A and IkappaB interact in yeast-two-hybrid systems, when transiently overexpressed in 293 cells, and as recombinant proteins in vitro. We further establish that the association between TCL1A and IkappaB is compatible with AKT binding to TCL1A, but incompatible with IkappaB binding to NF-kappaB. By interfering with the inhibition of NF-kappaB by IkappaB, TCL1A may increase the concentration of free NF-kappaB molecules sufficiently to trigger expression of anti-apoptotic genes. Thus our data suggest an additional route by which TCL1A might cause cancer.
###end p 3
###begin title 4
Introduction
###end title 4
###begin p 5
###xml 329 333 329 333 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TCL1</italic>
###xml 440 444 440 444 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TCL1</italic>
###xml 702 705 702 705 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006567-Teitell1">[1]</xref>
###xml 707 710 707 710 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006567-Noguchi1">[2]</xref>
###xml 48 54 <span type="species:ncbi:9606">humans</span>
###xml 495 500 <span type="species:ncbi:9606">human</span>
###xml 558 563 <span type="species:ncbi:9606">human</span>
TCL1-family proteins (TCL1A, TCL1B and MTCP1 in humans) are 13-15 kDa non-enzymatic interaction modules. Their restricted physiological expression and apparent lack of auto-regulatory mechanisms suggest that they are mainly regulated by tightly controlled gene expression levels. Normal time- and tissue-restricted expression of TCL1 genes is important for efficient fertility, and the development of T and B cell lineages. Deregulation of TCL1 expression can cause the transformation of mature human T and B lymphocytes, and is associated with a variety of human diseases, including T-cell prolymphocytic leukaemia, B-cell chronic leukaemia (B-CLL), B-cell lymphoma and germ-cell tumours [reviewed in [1], [2]].
###end p 5
###begin p 6
###xml 143 146 143 146 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006567-Laine1">[3]</xref>
###xml 148 151 148 151 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006567-Pekarsky1">[4]</xref>
###xml 244 247 244 247 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006567-Auguin1">[5]</xref>
###xml 377 382 377 382 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">trans</italic>
###xml 472 475 472 475 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006567-Teitell1">[1]</xref>
###xml 477 480 477 480 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006567-Noguchi1">[2]</xref>
###xml 572 575 572 575 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006567-Manning1">[6]</xref>
###xml 687 690 679 682 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006567-Ozes1">[7]</xref>
###xml 890 893 866 869 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006567-Hayden1">[8]</xref>
TCL1A is a co-activator of AKT, a serine/threonine protein kinase that regulates many cellular processes, including proliferation and survival [3], [4]. TCL1A forms homodimers, and each protomer binds one pleckstrin homology (PH) domain of AKT [5]. Co-activation may thus result from stabilising AKT in an open (active) conformation, from promoting AKT auto-phosphorylation in trans, and/or from reinforcing AKT attachment to the membrane, where its effectors are located [1], [2]. Activated AKT can promote cell survival by phosphorylating downstream targets such as BAD [6]. AKT can also activate the NF-kappaB transcription factor, possibly by phosphorylating the IkappaB kinase (IKK)[7]. Phosphorylated IKK phosphorylates IkappaB, leading to dissociation of the IkappaB:NF-kappaB complex. Liberated NF-kappaB subsequently translocates to the nucleus to activate survival-inducing genes [8].
###end p 6
###begin p 7
###xml 321 324 321 324 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006567-Teitell1">[1]</xref>
###xml 512 515 508 511 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006567-Pekarsky2">[9]</xref>
###xml 586 590 578 582 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006567-Pekarsky3">[10]</xref>
###xml 203 218 <span type="species:ncbi:10090">transgenic mice</span>
###xml 223 230 <span type="species:ncbi:9606">patient</span>
###xml 486 491 <span type="species:ncbi:10090">mouse</span>
However, the effects of TCL1A on AKT are insufficient to fully explain TCL1A oncogenesis. For example, AKT phosphorylation or inactivation kinetics do not consistently relate to TCL1A expression in both transgenic mice and patient-derived neoplasia, and AKT activation alone does not necessarily cause tumours in B cells [1]. This suggests that additional effects, and effectors, of TCL1A exist. Recently, it was reported that the NF-kappaB pathway is important for B-CLL in transgenic mouse models (reviewed in [9]), and that TCL1A activates NF-kappaB through an AKT-independent route [10]. Corroborating an AKT-independent targeting of NF-kappaB by TCL1A, we here report that TCL1A binds directly to the NF-kappaB inhibitor IkappaB.
###end p 7
###begin title 8
Results
###end title 8
###begin p 9
###xml 221 225 201 205 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006567-Huxford1">[11]</xref>
###xml 227 231 207 211 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006567-Jacobs1">[12]</xref>
###xml 233 242 213 222 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006567-g001">Figure 1a</xref>
###xml 428 437 392 401 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006567-g001">Figure 1b</xref>
###xml 527 536 483 492 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006567-g001">Figure 1c</xref>
###xml 690 698 638 646 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In vitro</italic>
###xml 1012 1022 945 955 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Drosophila</italic>
###xml 1049 1059 982 992 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0006567.s001">Figure S1a</xref>
###xml 81 86 <span type="species:ncbi:4932">yeast</span>
###xml 1012 1022 <span type="species:ncbi:7227">Drosophila</span>
In a search for additional partners of TCL1A, we identified IkappaBalpha through yeast two-hybrid screening. The prey consisted of residues 73-317 of IkappaBalpha, and included the six ankyrin repeats that bind NF-kappaB [11], [12] (Figure 1a). After over-expression of IkappaBalpha and FLAG-TCL1A in 293 cells, IkappaBalpha coimmunoprecipitated with TCL1A, demonstrating that these proteins can interact in a cellular context (Figure 1b). GST-TCL1A interacted significantly more strongly with IkappaBalpha than did GST-MTCP1 (Figure 1c). Conversely, two-hybrid, gel shift, and fluorescence anisotropy assays failed to detect an interaction between MTCP1 and IkappaBalpha (data not shown). In vitro, GST-TCL1A bound the AKTbeta PH domain (AKT_PH; residues 1-118), and an all-cysteine-to-serine (7CS) mutant of the IkappaBalpha ankyrin domain (IkappaB_ank, residues 67-302; the C->S substitutions were made to avoid non-specific aggregation through cys-cys di-sulphide bridges), but not the ankyrin domain of the Drosophila signalling protein Notch (Figure S1a).
###end p 9
###begin title 10
Cell-based binding assays.
###end title 10
###begin p 11
###xml 223 225 215 217 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">35</sup>
###xml 264 269 240 245 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1&#8211;253</sub>
###xml 282 290 258 266 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 320 326 <span type="species:ncbi:9986">rabbit</span>
(a) Schematic representation of IkappaBalpha. (b) Co-immunoprecipitation assay. Input 2%: 2% of the whole extract used for the immunoprecipitation. IP control: Immunoprecipitation with irrelevant antibody (anti-HA). (c,d) [35S]-labeled IkappaBalpha or IkappaBalpha1-253 produced by in vitro transcription/translation in rabbit reticulocytes lysate, were incubated with GST, GST-MTCP1 and GST-TCL1A immobilized on glutathione-sepharose beads. Bound proteins were resolved by 12% SDS-PAGE and detected by autoradiography.
###end p 11
###begin p 12
###xml 80 83 72 75 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">7CS</sup>
###xml 113 121 105 113 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006567-g002">Figure 2</xref>
###xml 123 135 115 127 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0006567.s001">Figure S1b,c</xref>
###xml 226 227 218 219 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</sub>
###xml 305 308 291 294 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006567-Auguin1">[5]</xref>
###xml 310 317 296 303 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0006567-t001">Table 1</xref>
###xml 323 333 309 319 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0006567.s002">Figure S2a</xref>
###xml 359 362 341 344 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">7CS</sup>
###xml 371 372 353 354 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</sub>
###xml 396 404 372 380 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006567-g003">Figure 3</xref>
###xml 440 443 412 415 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">7CS</sup>
###xml 521 522 493 494 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</sub>
###xml 707 717 669 679 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0006567.s002">Figure S2b</xref>
###xml 773 776 731 734 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">7CS</sup>
###xml 862 863 816 817 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</sub>
###xml 1060 1069 1001 1010 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006567-g002">Figure 2c</xref>
Native SDS PAGE gel shift assays showed that AKT_PH, IkappaB_ank and IkappaB_ank7CS retarded migration of TCL1A (Figure 2, Figure S1b,c). Using isothermal titration calorimetry (ITC), TCL1A displayed a dissociation constant (KD) of 7.5+/-1.0 microM for AKT_PH, in agreement with previous NMR measurements [5] (Table 1, and Figure S2a). TCL1A bound IkappaB_ank7CS with a KD of 0.71+/-0.07 microM (Figure 3). Placing the 1:1 TCL1A:IkappaB_ank7CS complex in the ITC cell slightly increased the affinity of injected AKT_PH (KD = 5.1+/-0.5 microM), as compared to titrations with only TCL1A in the cell. This showed that binding of IkappaB_ank and AKT_PH to TCL1A are compatible and slightly cooperative events (Figure S2b). Conversely, when the cell was filled with IkappaB_ank7CS bound to the NF-kappaB family member RELA, injection of TCL1A yielded curves with a KD>>50 microM, inferring that binding of TCL1A and RELA to IkappaB_ank are incompatible events (data not shown). Competition between TCL1A and RELA for IkappaB_ank was confirmed by gel shift assays (Figure 2c).
###end p 12
###begin title 13
Native gel shift assays.
###end title 13
###begin p 14
###xml 184 187 180 183 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">7CS</sup>
(a-c): Bands corresponding to the complexes formed are indicated on the right of each figure. (b,c): The three lanes on the right correspond to increasing concentrations of IkappaB_ank7CS (b) or RELA (c).
###end p 14
###begin title 15
ITC analysis.
###end title 15
###begin p 16
###xml 81 84 73 76 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">7CS</sup>
TCL1A at 470 microM was injected into the measurement cell containing IkappaB_ank7CS at 45 microM. The titration was carried out at 20degreesC. The upper panel shows the binding isotherm, the lower panels shows the integrated heats.
###end p 16
###begin title 17
Summary of ITC data.
###end title 17
###begin p 18
n.d.: not determined.
###end p 18
###begin p 19
###xml 62 65 62 65 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006567-Auguin1">[5]</xref>
A 1:1 stoichiometry can be deduced from our previous analyses [5].
###end p 19
###begin p 20
###xml 205 209 201 205 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006567-Koch1">[13]</xref>
###xml 361 364 349 352 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">7CS</sup>
###xml 432 442 420 430 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0006567.s003">Figure S3a</xref>
###xml 453 462 441 450 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ab initio</italic>
###xml 494 498 482 486 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006567-Koch1">[13]</xref>
###xml 580 581 568 569 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sup>
###xml 583 584 571 572 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 651 652 635 636 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sup>
###xml 654 655 638 639 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 827 830 811 814 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006567-Auguin1">[5]</xref>
###xml 832 836 816 820 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006567-Hoh1">[14]</xref>
###xml 885 894 869 878 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ab initio</italic>
###xml 941 945 925 929 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006567-Svergun1">[15]</xref>
###xml 963 972 947 956 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ab initio</italic>
###xml 1055 1057 1039 1041 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;1</sup>
###xml 1091 1095 1073 1077 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006567-Svergun2">[16]</xref>
###xml 1097 1107 1079 1089 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0006567.s003">Figure S3b</xref>
###xml 1222 1231 1204 1213 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006567-g004">Figure 4b</xref>
###xml 1350 1354 1332 1336 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006567-Hoh1">[14]</xref>
###xml 1379 1383 1357 1361 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006567-Huxford1">[11]</xref>
###xml 1385 1389 1363 1367 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006567-Jacobs1">[12]</xref>
###xml 1409 1417 1387 1395 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ab inito</italic>
###xml 1601 1610 1567 1576 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006567-g001">Figure 1d</xref>
In the absence of successful TCL1A:IkappaB crystallisation trials, we used small angle X-ray scattering (SAXS) to obtain structural information on the complex. Guinier analysis and data processing by GNOM [13] established a radius of gyration of 4.5+/-0.2 nm and a maximum diameter of 15.0+/-0.5 nm. The P(r) distance distribution obtained for TCL1A:IkappaB_ank7CS displayed a triangular shape indicative for an elongated particle (Figure S3a). Initial ab initio shape calculations with DAMMIN [13] without symmetry constraints yielded elongated particles with a volume of 12.7x104 A3, comparable to the one of a 2x(TCL1A:IkappaB_ank) complex (11.0x104 A3, calculated without hydration shell). The Z-shape of these reconstructions was suggestive of a P2 symmetry (data not shown). Because TCL1A forms stable dimers in solution [5], [14], we subsequently used P2 symmetry for iterative ab initio shape reconstructions with the program GASBOR [15]. The best scored ab initio structure out of 40 individual GASBOR runs fitted data between q = 0.02 and 0.45 A-1 with a chi value of 1.02 (CRYSOL [16]; Figure S3b). This SAXS envelope is composed of a trapeze-shaped central domain, and two laterally attached rod-like domains (Figure 4b). The dimensions of the central and rod-like domains correspond to those of the crystal structures of the TCL1A dimer [14] and IkappaB_ank monomer [11], [12], respectively. The ab inito shape suggested that TCL1A binds either to the N- or C-terminal ankyrin repeats of IkappaB_ank. Since the C-terminal sixth ankyrin repeat of IkappaBalpha was dispensable for binding (Figure 1d), our analysis supports that TCL1A principally contacts the first N-terminal ankyrin repeats of IkappaBalpha.
###end p 20
###begin title 21
SAXS analysis.
###end title 21
###begin p 22
###xml 199 203 199 203 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006567-Hoh1">[14]</xref>
###xml 311 314 311 314 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006567-Auguin1">[5]</xref>
###xml 376 380 372 376 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006567-Jacobs1">[12]</xref>
###xml 631 652 623 644 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s4">Materials and Methods</xref>
###xml 692 701 684 693 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ab initio</italic>
(a) SAXS curve (red) calculated from the molecular model depicted in b, fitted to SAXS data (black). (b) Best-scored SASREF model (surface representation). The TCL1A dimer (taken from PDB entry 1JSG [14]) is shown in two shades of violet. The AKT_PH binding sites of TCL1A (determined previously by NMR mapping [5]) are coloured yellow. IkappaB_ank (taken from PDB entry 1NFI [12]) is shown in blue. The disordered 20 C-terminal tail residues of IkappaB_ank (dark blue), and 7 N-terminal residues of TCL1A (light pink) were not included in the crystal structures. These fragments were modelled placed by SASREF as described in the Materials and Methods section. Because the dimensions of the ab initio GASBOR envelope (pink spheres) suggested that the 20 residues C-terminal tail residues of IkappaB_ank are pinned back onto the ankyrin repeats, this constraint was used in SASREF runs. We speculate that hydrophobic tail residues (such as F295 and F298) may cover hydrophobic surfaces on the ankyrin repeats that are also used by NF-kappaB. (c) The SASREF model is superimposed onto the 'filtered' average envelope (grey spheres) which was calculated by DAMAVER (file 'damfilt') from the 20% top SASREF solutions. The superimposition in DAMAVER was achieved allowing use of enantiomers. At the low resolution used, models where the C-terminus of the left IkappaB_ank molecule points down, and the right one up (using the orientation of the lower panel) resemble enantiomers of the model displayed. Since SAXS is unable to distinguish between enantiomers, models with both IkappaB_ank orientations were found among the top 20% best scored SASREF models; the orientation of the model displayed is used by 70% of the top 20% solutions, and may therefore be more likely.
###end p 22
###begin p 23
###xml 127 131 123 127 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006567-Koch1">[13]</xref>
###xml 371 375 363 367 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006567-Volkov1">[17]</xref>
###xml 533 535 523 525 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;1</sup>
###xml 546 555 536 545 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006567-g004">Figure 4a</xref>
###xml 583 592 573 582 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ab initio</italic>
###xml 610 619 600 609 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006567-g004">Figure 4b</xref>
We next used the crystal structures of TCL1A and IkappaB_ank to perform SAXS-guided rigid body docking with the program SASREF [13]. The information that TCL1A binds to the N- and not the C-terminal of IkappaB_ank was used as a constraint. The best-scored 20 structures out of 100 individual Monte-Carlo-based simulated annealing calculations were averaged using DAMAVER [17]. The representative structure determined by DAMAVER, which was also the one with the best fit of all SASREF runs (chi fit to data between q = 0.02 and 0.40 A-1 was 1.02; Figure 4a), corresponded well to the ab initio GASBOR envelope (Figure 4b). Rg and Dm values for this structure (42.3 A and 144.2 A, respectively, calculated without hydration shell) were in good agreement with values obtained from GNOM and Guinier analysis for the hydrated particle (4.5+/-0.2 nm and 15.0+/-0.5 nm).
###end p 23
###begin p 24
###xml 238 242 226 230 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006567-Huxford1">[11]</xref>
###xml 244 248 232 236 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006567-Jacobs1">[12]</xref>
###xml 354 357 338 341 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006567-Auguin1">[5]</xref>
Our structural analysis suggests that TCL1A uses a binding site roughly opposite to its dimerisation site to interact with the first one or two ankyrin repeats of IkappaB_ank. Thus TCL1A may compete with helices alphaA and alphaB of RELA [11], [12]. The IkappaB_ank binding site is close to, but not overlapping with, the AKT_PH binding surface on TCL1A [5], corroborating that TCL1A can bind IkappaB and AKT simultaneously.
###end p 24
###begin title 25
Discussion
###end title 25
###begin p 26
###xml 91 94 87 90 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006567-Pekarsky2">[9]</xref>
###xml 96 100 92 96 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006567-Pekarsky3">[10]</xref>
###xml 102 106 98 102 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006567-Despouy1">[18]</xref>
###xml 207 215 195 203 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 310 318 298 306 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 600 604 560 564 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006567-Huxford1">[11]</xref>
###xml 606 610 566 570 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006567-Jacobs1">[12]</xref>
###xml 220 225 <span type="species:ncbi:4932">yeast</span>
Several lines of evidence suggest an AKT-independent action of TCL1A on NF-kappaB pathways [9], [10], [18]. We here sharpened this picture by showing that TCL1A and the NF-kappaB inhibitor IkappaB associate in vitro, in yeast-two-hybrid systems, and when transiently overexpressed in 293 cells. We also showed in vitro that TCL1A competed with NF-kappaB for binding to IkappaB, suggesting that TCL1A interferes with the inhibitory interaction between IkappaB and NF-kappaB. Since TCL1A binds to the same first two ankyrin repeats of IkappaB which also interact with helices alphaA and alphaB of RELA [11], [12], it is likely that TLC1A and RELA use overlapping binding sites on IkappaB. However, we can not exclude that IkappaB binding to one partner causes conformational changes (such as a slight change in the curvature of the ankyrin repeats) that affect allosterically the (distant) binding site of the other partner.
###end p 26
###begin p 27
###xml 218 222 206 210 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006567-Pekarsky3">[10]</xref>
On a cellular level, the effect expected to arise from the competition of TCL1A and NF-kappaB for IkappaB would be an AKT-independent NF-kappaB-activation by TCL1A. This was indeed recently observed by Pekarsky et al. [10]. These authors reported that this effect involves the association between TCL1A and p300. The molecular details of the association between TCL1A and p300 remain elusive. Since both proteins are multivalent adaptor proteins, sequential or concomitant interactions of TCL1A with IkappaB are not excluded, and may be necessary for activation of NF-kappaB.
###end p 27
###begin p 28
###xml 149 153 149 153 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006567-Pekarsky3">[10]</xref>
###xml 155 159 155 159 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006567-Despouy1">[18]</xref>
###xml 442 446 430 434 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006567-Pekarsky3">[10]</xref>
###xml 448 452 436 440 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006567-Despouy1">[18]</xref>
The description of several AKT-independent TCL1A targets suggests that TCL1A affects a number of alternative and interconnected signalling pathways ([10], [18], and this report). Indeed, depending on the cell type and experimental conditions, both NF-kappaB activation and inhibition by TCL1A were reported, as well as alternative, NF-kappaB independent routes (inhibition of PKCtheta and ERK activation, or of AP-1 transcriptional activity) [10], [18]. Thus, TCL1A increasingly appears as a polyvalent adaptor protein, whose cellular action is dramatically affected by its sub-cellular concentration and the availability of potential targets.
###end p 28
###begin p 29
###xml 142 146 130 134 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006567-Bergqvist1">[19]</xref>
###xml 258 262 242 246 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006567-Tergaonkar1">[20]</xref>
###xml 1060 1061 1020 1021 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 1061 1064 1021 1024 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006567-Noguchi1">[2]</xref>
###xml 1066 1069 1026 1029 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006567-Laine1">[3]</xref>
The affinity we measured between IkappaB and TCL1A was about 1,000 fold weaker than the one previously reported between IkappaB and NF-kappaB [19]. However, since only a minor fraction of cytoplasmic NF-kappaB is enough to trigger transcriptional activation [20], even weak competition by TCL1A is expected to alter gene expression through NF-kappaB. Yet this effect will be caused by only a negligible fraction of cellular IkappaB and NF-kappaB, which may explain why we were unable to detect significant amounts of TCL1A-IkappaB complexes in absence of transient overexpression, as searched for in 697 and Sup-T11 TCL1-positive leukaemic cell lines (data not shown). In addition, a biologically significant effect on the IkappaB:NF-kappaB complex is likely to require TCL1A over-expression following chromosomal translocation, and/or additional factors, such as AKT, p300, or factors associated with a particular cell activation level. Importantly, TCL1A also needs co-stimulatory signals to induce AKT activation (possibly the association of AKT_PH with PIP3[2], [3]), and the requirement of co-activators may constitute an additional control mechanism for TCL1A.
###end p 29
###begin p 30
###xml 57 65 53 61 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 195 200 187 192 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TCL1A</italic>
###xml 254 257 242 245 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cis</italic>
###xml 277 280 265 268 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006567-Ozes1">[7]</xref>
Given that TCL1A binds IkappaB and AKT_PH simultaneously in vitro, TCL1A may act on IkappaB and AKT synergistically or independently. In its physiological location, the 5' promoter region of the TCL1A gene contains, among others, an NF-kappaB-responsive cis-regulatory element [7]. Through the action of TCL1A on IkappaB or AKT, this element may produce a positive feed-back loop to enhance TCL1A expression. Thus, the association between TCL1A and IkappaB could contribute to transcriptional regulation of TCL1A.
###end p 30
###begin p 31
###xml 49 56 49 56 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
Future research will be necessary to clarify the in vivo significance and role of the TCL1A-IkappaB interaction for oncogenesis. However, given that TCL1A appears to be a polyvalent adaptor protein with multiple cellular partners, it will be far from trivial to design a cell-based assay that allows observing a molecular effect based solely on this TCL1A-IkappaB interaction. Moreover, because only an extremely low fraction of cellular IkappaB:NF-kappaB complexes is predicted to be affected by TCL1A, it will be difficult to use intracellular detection methods based on endogenous protein (for example co-localisation studies by immunofluorescence, or co-immunoprecipation experiments). The identification of potential binding surfaces by our structural characterisation of the TCL1A-IkappaB interaction may however help resolving these issues.
###end p 31
###begin title 32
Materials and Methods
###end title 32
###begin title 33
###xml 0 5 <span type="species:ncbi:4932">Yeast</span>
Yeast two-hybrid screening of TCL1A
###end title 33
###begin p 34
###xml 69 73 69 73 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006567-Bouhamdan1">[21]</xref>
###xml 333 334 333 334 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 4 9 <span type="species:ncbi:4932">yeast</span>
###xml 87 92 <span type="species:ncbi:4932">yeast</span>
The yeast two hybrid screening was performed as previously described [21]. Briefly the yeast reporter strain HF7c was transformed by the lithium acetate method with the bait plasmid pGBT10-TCL1A. After selection and transformation with a peripheral blood mononuclear cell cDNA library cloned into the pGAD plasmid, approximately 2.106 clones were screened for HIS+betaGAL+ colonies. Out of the 30 HIS+betaGAL+ colonies sequenced, 28 corresponded to the 735 nucleotides at the 3' end of IkappaBalpha transcripts.
###end p 34
###begin title 35
Binding analysis through retention by glutathione-sepharose-bound GST-TCL1A
###end title 35
###begin p 36
###xml 54 61 54 61 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. coli</italic>
###xml 362 365 352 355 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">7CS</sup>
###xml 650 652 640 642 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">35</sup>
###xml 702 707 676 681 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1&#8211;253</sub>
###xml 972 977 930 935 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1&#8211;253</sub>
###xml 54 61 <span type="species:ncbi:110766|species:ncbi:562">E. coli</span>
###xml 374 384 <span type="species:ncbi:7227">Drosophila</span>
###xml 610 616 <span type="species:ncbi:9986">rabbit</span>
Recombinant GST-TCL1A and GST-MTCP1 were expressed in E. coli, bound to glutathione-sepharose beads (Pharmacia), and placed into Handee Centrifuge Columns. Unbound material was removed by washing the beads four times with 100 column volumes of TN300 (10 mM Tris, pH 7.4 and 300 mM NaCl). Beads were incubated for 1 h at 4degreesC with 3 mg of AKT_PH, IkappaB_ank7CS, or the Drosophila Notch ankyrin-repeat protein and washed with 15 column volumes with TN300. The bound proteins were visualized using SDS PAGE gel under denaturing conditions. Alternatively, GST proteins bound to the beads were incubated with rabbit reticulocyte lysates containing [35S]-labeled translated IkappaBalpha or IkappaBalpha1-253 (T7 Quick Coupled Transcription/Translation System, Promega Madison, WI). Equal loading of the GST fusion proteins was confirmed by Coomassie staining. Input corresponds to 5% of the total protein content used for the pull-down. Bound IkappaBalpha and IkappaBalpha1-253 were recovered in SDS loading buffer, resolved by 12% SDS-PAGE and analyzed by autoradiography of dried gels.
###end p 36
###begin title 37
Co-immunoprecipitation assay
###end title 37
###begin p 38
###xml 198 202 190 194 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006567-Despouy2">[22]</xref>
###xml 240 245 <span type="species:ncbi:10090">mouse</span>
293 cells were transiently transfected with pCMV2-FLAG-TCL1A (Sigma-Aldrich, Saint Quentin Fallavier, France) and pCMV-IkappaBalpha, using the calcium phosphate precipitation technique as described [22]. Cell extracts were incubated with a mouse anti-Flag antibody (Sigma-Aldrich) for 16 h and then with protein G-Sepharose (Amersham Pharmacia Biotech) for an additional hour. The immunocomplexes were recovered by centrifugation, washed and resolved by SDS-PAGE. The immunoprecipitated proteins were revealed by immunoblotting and chemiluminescence.
###end p 38
###begin title 39
Western Blot analysis
###end title 39
###begin p 40
###xml 200 205 <span type="species:ncbi:10090">mouse</span>
###xml 358 363 <span type="species:ncbi:10090">mouse</span>
###xml 378 389 <span type="species:ncbi:3704">horseradish</span>
For Western Blot analysis, the native gels were applied to a PolyScreen PVDF transfer membrane (NEN Life Science Products). Membranes were treated as suggested by the manufacturer, and incubated with mouse anti-IkappaBalpha antibody (1 h at room temperature), followed by membrane washing in the Tris-buffered saline. Membranes were then incubated with anti-mouse IgG linked to horseradish (30 min at room temperature). Membranes were washed following the manufacturer's directions, and ECL detection reagents were added. Kodak biomax light film was exposed to membranes for approximately25 s. The positions of the complexes formed are indicated.
###end p 40
###begin title 41
Recombinant protein production
###end title 41
###begin p 42
###xml 47 53 43 49 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">67&#8211;302</sub>
###xml 240 244 224 228 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006567-Huxford2">[23]</xref>
###xml 246 250 230 234 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006567-Kiernan1">[24]</xref>
###xml 284 289 265 270 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1&#8211;118</sub>
###xml 326 330 307 311 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006567-Hoh1">[14]</xref>
###xml 332 336 313 317 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006567-Auguin2">[25]</xref>
###xml 365 371 342 348 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">67&#8211;302</sub>
###xml 371 374 348 351 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">7CS</sup>
###xml 387 390 360 363 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">7CS</sup>
###xml 519 529 492 502 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Drosophila</italic>
###xml 34 39 <span type="species:ncbi:9606">human</span>
###xml 252 257 <span type="species:ncbi:9606">Human</span>
###xml 268 273 <span type="species:ncbi:9606">human</span>
###xml 519 529 <span type="species:ncbi:7227">Drosophila</span>
The pET11a expression plasmid for human IkappaB67-302 (IkappaB_ank) was provided by G. Ghosh. The NF-kappaB family member RELA/p65, cloned into pGEX2T, was provided by M. Benkirane. IkappaB and RELA were expressed and purified as described [23], [24]. Human TCL1A and human AKTbeta PH1-118 (AKT_PH) were produced as published [14], [25]. The Cys->Ser mutant IkappaB67-3027CS (IkappaB_ank7CS) was obtained using Stratagene's QuikChange multi-site directed mutagenesis Kit. The purified recombinant ankyrin domain of the Drosophila signalling protein Notch was provided by J.-B. Rouget.
###end p 42
###begin title 43
PAGE gel shift assays
###end title 43
###begin p 44
###xml 474 479 <span type="species:ncbi:10090">mouse</span>
###xml 632 637 <span type="species:ncbi:10090">mouse</span>
###xml 652 663 <span type="species:ncbi:3704">horseradish</span>
Undenatured (native) polyacrylamide gel electrophoresis (PAGE) was performed with purified recombinant proteins. Running gels contained 15% (w/v) polyacrylamide and 0.125 M Tris (pH 6.8). Stacking gels contained 5% (w/v) polyacrylamide and 0.375 M Tris (pH 8.8). For additional Western blot analysis, the native gels were applied to a PolyScreen PVDF transfer membrane (NEN Life Science Products). Membranes were treated as suggested by the manufacturer, and incubated with mouse anti-IkappaBalpha antibody (1 h at room temperature), followed by membrane washing in the Tris-buffered saline. Membranes were then incubated with anti-mouse IgG linked to horseradish (30 min at room temperature). Membranes were washed following the manufacturer's directions, and ECL detection reagents were added. Kodak biomax light film was exposed to membranes for approximately25 s.
###end p 44
###begin title 45
Isothermal titration calorimetry (ITC)
###end title 45
###begin p 46
###xml 27 30 23 26 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">7CS</sup>
###xml 121 124 113 116 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">7CS</sup>
###xml 711 714 671 674 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">7CS</sup>
###xml 885 888 833 836 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">7CS</sup>
Purified TCL1A, IkappaB_ank7CS, RELA and AKT_PH were extensively dialysed in degassed ITC buffer. The TCL1A - IkappaB_ank7CS titrations were carried out in a buffer similar to the SAXS measurement (10 mM Tris pH 7.4, 300 mM NaCl, 1 mM beta-mercapto ethanol). All other titrations were carried out in 20 mM sodium phosphate pH 7.1, 300 mM NaCl, 2 mM EGTA and 1 mM beta-mercapto ethanol. ITC was performed at 20degreesC with a VP-ITC microcalorimeter from MicroCal Incorporated. For the AKT_PH -TCL1A titration, TCL1A was placed in the 1.4 mL sample cell at a concentration of 40 microM, and AKT_PH (490 microM) was injected using 10-15 microl injections every 300 s. For the IkBalpha-TCL1A titration, IkappaB_ank7CS (45 microM) was kept in the sample cell, and TCL1A (470 microM) was injected. Competition experiments were performed by placing equimolar amounts of TCL1A and IkappaB_ank7CS in the sample cell, and injecting AKT_PH. For all protein-protein titrations, control experiments were performed where the corresponding protein was injected in buffer alone. The resulting heats were subtracted from the protein-protein titrations prior to analysis. Data were fitted with Microcal Origin software.
###end p 46
###begin title 47
SAXS analysis
###end title 47
###begin p 48
###xml 234 237 219 222 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">7CS</sup>
###xml 440 443 421 424 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">7CS</sup>
###xml 645 648 619 622 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">7CS</sup>
###xml 838 847 812 821 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ab initio</italic>
###xml 1000 1004 974 978 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006567-Koch1">[13]</xref>
###xml 1006 1010 980 984 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006567-Svergun2">[16]</xref>
###xml 1012 1016 986 990 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006567-Konarev1">[26]</xref>
###xml 1017 1021 991 995 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006567-Svergun3">[28]</xref>
###xml 1067 1069 1041 1043 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;1</sup>
###xml 1085 1087 1059 1061 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;1</sup>
###xml 1222 1226 1196 1200 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006567-Hoh1">[14]</xref>
###xml 1345 1349 1315 1319 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006567-Jacobs1">[12]</xref>
###xml 1876 1878 1838 1840 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;1</sup>
###xml 1894 1896 1856 1858 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;1</sup>
Data used for this SAXS analysis were collected at beamline X33, at DESY, EMBL, Hamburg, at 10degreesC, lambda = 1.5 A. Additional preliminary data were collected at the ESRF beamline ID14-3. For SAXS analysis of the TCL1A:IkappaB_ank7CS complex, the partners were pre-purified individually, then mixed in a 1:1 ratio, and applied to a S200 size-exclusion column (Pharmacia). Only eluted fractions corresponding to the 2x2 TCL1A:IkappaB_ank7CS dimer were used for SAXS. Samples were kept in 10 mM Tris, pH 7.4, 300 mM NaCl, 1 mM beta-mercapto ethanol and supplemented with 5 mM DTT prior to exposure. Data collected on purified TCL1A:IkappaB_ank7CS at 1 and 7 mg/ml were merged to combine the aggregate-free low resolution-part of the 1 mg/ml scattering curve with the reduced noise at high resolution of the 7 mg/ml data. Data analysis, ab initio shape calculations, and rigid body docking were performed using programs by S. Svergun and colleagues (PRIMUS, GNOM, DAMMIN, CRYSOL, DAMAVER and SASREF [13], [16], [26]-[28]). For GASBOR different q ranges (0.020-0.45 A-1 or 0.028-0.40 A-1) gave very similar results. For SASREF rigid body docking, P2 symmetry was used. The TCL1A dimer was obtained from the PDB entry 1JSG [14]), and this dimeric arrangement was kept fixed during rigid body docking. IkappaB_ank was obtained from PDB entry 1NFI [12]. The regions not included into the crystallographic models (7 N-terminal residues for TCL1A, and 20 C-terminal residues for IkappaB_ank) were modelled as extended unstructured regions and included as rigid fragments in SASREF modelling. For this, the 20 C-terminal residues of IkappaB_ank were divided into two rigid 10-residue fragments. The fragments forming one polypeptide chain were connected using the constraint that connecting residues lie within 4.0 A of each other. SASREF models for different q ranges (0.020-0.40 A-1 or 0.028-0.40 A-1) were very similar.
###end p 48
###begin title 49
Supporting Information
###end title 49
###begin p 50
###xml 361 366 <span type="species:ncbi:10090">mouse</span>
Binding assays. (a) Glutathione-sepharose beads containing GST_TCL1A alone, or GST_TCL1A and indicated ligands, were washed and analysed by SDS PAGE gels as described in Supplementary Methods. Notch ank has the same molecular weight (26 kDa) as IkappaB_ank. (b) Native gel shift assays, stained with coomassie blue, or (c) revealed by Western blotting, using a mouse anti-IkappaBalpha antibody.
###end p 50
###begin p 51
(0.30 MB TIF)
###end p 51
###begin p 52
Click here for additional data file.
###end p 52
###begin p 53
Supporting ITC data. All experiments were performed at 20degreesC. Upper panels show the binding isotherms (black) and their control experiments (blue) where the syringe content was injected into the cell containing only buffer. Lower panels show integrated heats, after subtraction of heats from control experiments (dots). The black lines represent least-square fits of data. (a) ITC binding isotherm obtained when AKT_PH was injected into the TCL1A-containing cell. (b) ITC binding isotherm for AKT_PH injected into the cell containing the TCL1A:IkappaB_ank7CS complex.
###end p 53
###begin p 54
(0.19 MB DOC)
###end p 54
###begin p 55
Click here for additional data file.
###end p 55
###begin p 56
###xml 143 145 143 145 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;1</sup>
SAXS Distance distribution [P(r)] and SASREF results. (a) P(r) distance distribution, and (b) fit of best GASBOR model to data (q = 0.02-0.45 A-1).
###end p 56
###begin p 57
(0.06 MB DOC)
###end p 57
###begin p 58
Click here for additional data file.
###end p 58
###begin p 59
We thank G. Pierron for her contribution in two-hybrid screening, D. Auguin for comments, J.-B. Rouget for the Notch ankyrin protein, G. Ghosh and M. Benkirane for IkappaB and RELA expression plasmids, respectively. We are grateful to J.-B. Charbonnier for giving us access to protein expression and purification facilities for preparing the revised manuscript. We thank S. Miron for access to the ITC microcalorimeter. We thank J.-L. Pons and E. Richard for their assistance with computational analyses on the computer cluster of the Centre de Biochimie Structurale. We thank D. Svergun and his colleagues at the X33 beamline at EMBL/DESY, Hamburg, as well as P. Pernot and A. Round from the ESRF beamline ID14-3 for assistance with SAXS analysis.
###end p 59
###begin title 60
References
###end title 60
###begin article-title 61
The TCL1 family of oncoproteins: co-activators of transformation.
###end article-title 61
###begin article-title 62
Proto-oncogene TCL1: more than just a coactivator for Akt.
###end article-title 62
###begin article-title 63
The protooncogene TCL1 is an Akt kinase coactivator.
###end article-title 63
###begin article-title 64
Tcl1 enhances Akt kinase activity and mediates its nuclear translocation.
###end article-title 64
###begin article-title 65
Structural basis for the co-activation of protein kinase B by T-cell leukemia-1 (TCL1) family proto-oncoproteins.
###end article-title 65
###begin article-title 66
AKT/PKB signaling: navigating downstream.
###end article-title 66
###begin article-title 67
NF-kappaB activation by tumour necrosis factor requires the Akt serine-threonine kinase.
###end article-title 67
###begin article-title 68
Shared principles in NF-kappaB signaling.
###end article-title 68
###begin article-title 69
Animal models for chronic lymphocytic leukemia.
###end article-title 69
###begin article-title 70
Tcl1 functions as a transcriptional regulator and is directly involved in the pathogenesis of CLL.
###end article-title 70
###begin article-title 71
The crystal structure of the IkappaBalpha/NF-kappaB complex reveals mechanisms of NF-kappaB inactivation.
###end article-title 71
###begin article-title 72
Structure of an IkappaBalpha/NF-kappaB complex.
###end article-title 72
###begin article-title 73
Small-angle scattering: a view on the properties, structures and structural changes of biological macromolecules in solution.
###end article-title 73
###begin article-title 74
###xml 24 28 24 28 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TCL1</sup>
###xml 24 28 24 28 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>TCL1</sup></italic>
Crystal structure of p14TCL1, an oncogene product involved in T-cell prolymphocytic leukemia, reveals a novel beta-barrel topology.
###end article-title 74
###begin article-title 75
Determination of domain structure of proteins from X-ray solution scattering.
###end article-title 75
###begin article-title 76
CRYSOL - a Program to Evaluate X-ray Solution Scattering of Biological Macromolecules from Atomic Coordinates.
###end article-title 76
###begin article-title 77
###xml 14 23 14 23 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ab initio</italic>
Uniqueness of ab initio shape determination in small-angle scattering.
###end article-title 77
###begin article-title 78
The TCL1 oncoprotein inhibits activation-induced cell death by impairing PKCtheta and ERK pathways.
###end article-title 78
###begin article-title 79
Thermodynamics reveal that helix four in the NLS of NF-kappaB p65 anchors IkappaBalpha, forming a very stable complex.
###end article-title 79
###begin article-title 80
Distinct roles of IkappaB proteins in regulating constitutive NF-kappaB activity.
###end article-title 80
###begin article-title 81
###xml 0 35 <span type="species:ncbi:11676">Human immunodeficiency virus type 1</span>
Human immunodeficiency virus type 1 Vpr protein binds to the uracil DNA glycosylase DNA repair enzyme.
###end article-title 81
###begin article-title 82
Cyclin D3 is a cofactor of retinoic acid receptors, modulating their activity in the presence of cellular retinoic acid-binding protein II.
###end article-title 82
###begin article-title 83
Preparation and crystallization of dynamic NF-kappa B.Ikappa B complexes.
###end article-title 83
###begin article-title 84
Post-activation turn-off of NF-kappa B-dependent transcription is regulated by acetylation of p65.
###end article-title 84
###begin article-title 85
###xml 82 87 <span type="species:ncbi:9606">human</span>
Solution structure and backbone dynamics of the pleckstrin homology domain of the human protein kinase B (PKB/Akt). Interaction with inositol phosphates.
###end article-title 85
###begin article-title 86
PRIMUS: a Window PC-based system for small-angle scattering data.
###end article-title 86
###begin article-title 87
Global rigid body modeling of macromolecular complexes against small-angle scattering data.
###end article-title 87
###begin article-title 88
Determination of the Regularization Parameter in Indirect-Transform Methods Using Perceptual Criteria.
###end article-title 88
###begin p 89
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 89
###begin p 90
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: This study was supported by the European Community-Research Infrastructure Action under the FP6 (RII3/CT/2004/5060008) for access to EMBL/DESY, Hamburg, and by the Association pour la Recherche contre le Cancer (ARC). V.R. received funding from ARC and the Ligue Nationale contre le Cancer. G.D. received funding from the Fondation de France and the Canceropole-Ile-de-France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
###end p 90

